Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs Vanguard Growth Index Fund ETF (VUG) Price & Performance

AbCellera Biologics IncTrade
Vanguard Growth Index Fund ETFTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Vanguard Growth Index Fund ETF — how do they compare? AbCellera Biologics Inc trades at $9.1 (market cap $2.99B), while Vanguard Growth Index Fund ETF trades at $89. Which is the better fit depends on your goals.

ABCLVUG
Market Cap
$2.99B
Sector
HealthSector/Thematic
52-Week High
$9.76$90.29
52-Week Low
$2.78$70.00
Enterprise Value
$2.58B

Returns comparison

Trailing returns across standard periods

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About Vanguard Growth Index Fund ETF

VUG is an index-based ETF that tracks the CRSP US Large Cap Growth Index, providing concentrated exposure to the largest and fastest-growing companies in the United States. It focuses on stocks with high growth potential across tech, communication, and consumer sectors, serving as a low-cost, high-conviction core holding for long-term capital appreciation.

Read more on VUG